Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AnteoTech Ltd ( (AU:ADO) ) has issued an update.
AnteoTech Ltd’s Life Sciences Business Unit is on track to achieve approximately A$0.93 million in sales for FY2025, marking a 130% increase over the previous year. The company has received a significant order from the Serum Institute of India, reflecting growing demand and a strengthening relationship. Despite some delays in the Vidcare project due to regulatory requirements, AnteoTech continues to expand its collaborations, including successful prototype development for KOMA Biotech in South Korea. These developments underscore AnteoTech’s strategic efforts to deepen customer relationships and expand its market presence.
More about AnteoTech Ltd
AnteoTech Ltd is a supplier of advanced material solutions for the battery materials and life sciences markets. The company leverages its market-leading binding chemical platform technology to develop and commercialize material solutions globally. Its Advanced Battery Technology division focuses on high-performance, sustainable materials, while the Life Sciences division provides advanced activation materials for diagnostic tests.
Average Trading Volume: 2,813,141
Technical Sentiment Signal: Sell
Current Market Cap: A$21.64M
See more data about ADO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue